Table 1.

Summary of AAM originating from outside the pelvi-perineal region

Author (reference)	Year	Location	Age	Sex	Size (cm)	Immunohistochemical exam	Surgical treatment	Resection margin (mm)	Adjuvant therapy	Disease-free survival (months)	Recurrence
Magalhaes F.TD [2]	1995	Larynx	63	F	2.0	• Negative: S-100	Tumorectomy	Unknown	No	1	Local recurrence
Yamashita Y [3]	2004	Oral floor	8	F	2.0	• Positive: vimentin • Negative: S-100, CD34	Surgical excision	10	No	24	None
Pai CY [4]	2008	Supraclavicular fossa	48	M	12 × 10	• Positive: vimentin, desmin, muscle-specific actin, ER • Negative: cytokeratin, S100, PgR	Wide excision after preoperative biopsy	Unknown	No	6	None
Choi YD [5]	2008	Lung	70	F	6.0 × 5.5	• Positive: vimentin, desmin, actin, ER, PgR • Negative: cytokeratin, S-100, CD34, bcl-2	Thoracoscopic surgery after preoperative needle biopsy	Unknown	No	8	None
Sylvester DC [6]	2010	Larynx	47	M	4.0 × 2.5	• Negative: S-100, desmin, CD34, SMA	Laryngofissure approach excision biopsy and covering tracheostomy	Unknown	No	48	None
Qi S [7]	2015	Liver	50	F	2.0 × 2.0	• Positive: vimentin, CD34, SMA • Negative: desmin, S-100, Ki-67, EMA, ER, PgR, CD99, CD10, CAM5.2, CK19	Partial hepatectomy	Unknown	No	6	None
Present case	2016	Liver	33	F	8.0 × 7.5	• Positive: vimentin, desmin, CD34, ER, PgR • Negative: S-100, EMA, CD99, HMB45, CK19	Subsegmentectomy	2	No	10	None

Abbreviations: AAM aggressive angiomyxoma, ER estrogen receptor, F female, M male, PgR progesterone receptor